Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
2.

Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.

Xu J, Li J, Chen J, Liu ZJ.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):331-40. doi: 10.17219/acem/29760. Review.

3.

Recent advances in the prevention of hepatocellular carcinoma recurrence.

Lu LC, Cheng AL, Poon RT.

Semin Liver Dis. 2014 Nov;34(4):427-34. doi: 10.1055/s-0034-1394141. Epub 2014 Nov 4. Review.

PMID:
25369304
4.

Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ.

Ann Surg Oncol. 2014 Mar;21(3):1010-5. Review.

PMID:
24121884
5.

NIH consensus development statement on management of hepatitis B.

Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Sorrell MF, Strader DB, Trotter HT.

NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29.

6.

Postoperative therapy options for hepatocellular carcinoma.

Zhong JH, Ma L, Li LQ.

Scand J Gastroenterol. 2014 Jun;49(6):649-61. doi: 10.3109/00365521.2014.905626. Epub 2014 Apr 10. Review.

PMID:
24716523
7.

[Hepatitis B virus (HBV) infection and hepatocarcinogenesis].

Pár A.

Orv Hetil. 2010 Jun 27;151(26):1045-53. doi: 10.1556/OH.2010.28881. Review. Hungarian.

PMID:
20558351
8.

[Advances in perioperative antiviral therapy for HBV/HCV-associated hepatocellular carcinoma].

Huang Y, Dong JH.

Zhonghua Gan Zang Bing Za Zhi. 2017 Jan 20;25(1):73-76. doi: 10.3760/cma.j.issn.1007-3418.2017.01.021. Review. Chinese.

PMID:
28297789
9.

How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?

Wang CC, Kao JH.

Expert Opin Pharmacother. 2016;17(7):911-9. doi: 10.1517/14656566.2016.1149165. Epub 2016 Feb 25. Review.

PMID:
26831361
10.

Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.

Cholongitas E, Papatheodoridis GV.

World J Gastroenterol. 2013 Dec 28;19(48):9189-97. doi: 10.3748/wjg.v19.i48.9189. Review.

11.

Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma.

Hsu YC, Wu CY, Lin JT.

Semin Oncol. 2015 Apr;42(2):329-38. doi: 10.1053/j.seminoncol.2014.12.023. Epub 2014 Dec 31. Review.

PMID:
25843737
12.

Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line.

Xia JF, Gao JJ, Inagaki Y, Kokudo N, Nakata M, Tang W.

Drug Discov Ther. 2013 Feb;7(1):1-8. Review.

13.

Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.

Zhou HY, Luo Y, Chen WD, Gong GZ.

J Gastroenterol Hepatol. 2015 Jun;30(6):977-83. doi: 10.1111/jgh.12917. Review.

PMID:
25689418
14.

Antiviral treatment for cirrhosis due to hepatitis C: a review.

Somasundaram A, Venkataraman J.

Singapore Med J. 2012 Apr;53(4):231-5. Review.

15.

[Clinicopathological study of juvenile hepatocellular carcinoma with hepatitis B virus infection].

Kitagawa S, Nakanuma Y, Kaizaki Y.

Nihon Rinsho. 2004 Aug;62 Suppl 8:381-6. Review. Japanese. No abstract available.

PMID:
15453351
16.

Prevention of hepatitis B virus-related hepatocellular carcinoma.

Lok AS.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S303-9. Review.

PMID:
15508098
17.

[Effect of nucleos(t)ide analog antiviral treatment on the occurrence of hepatitis B virus-associated hepatocellular carcinoma].

Xu M, Lan Y, Li Y.

Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):312-4. Review. Chinese. No abstract available.

PMID:
25199211
18.

[Hepatocarcinomas and hepatitis B virus].

Bourliere M, Gauthier AP.

Med Trop (Mars). 1994;54(3 Suppl):14-7. Review. French. No abstract available.

PMID:
7596255
19.

Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis.

Xia BW, Zhang YC, Wang J, Ding FH, He XD.

Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):458-68. doi: 10.1016/j.clinre.2014.12.003. Epub 2015 Jan 28. Review.

PMID:
25650304
20.

Role of antiviral treatment for HCC prevention.

Colombo M, Iavarone M.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):771-81. doi: 10.1016/j.bpg.2014.07.017. Epub 2014 Aug 23. Review.

PMID:
25260307

Supplemental Content

Support Center